Our findings are in accord with these studies indicating that RBMX binds to Lnc-FTX and enhances Lnc-FTX stability and suggesting that RBMX is of clinical significance to be one of potential therapeutic targets for HCC. The gene discussed is FTX; the disease is hepatocellular carcinoma.